These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
237 related articles for article (PubMed ID: 32503269)
1. In Vitro Effects of Ligand Bias on Primate Mu Opioid Receptor Downstream Signaling. Zhang X; Hutchins SD; Blough BE; Vallender EJ Int J Mol Sci; 2020 Jun; 21(11):. PubMed ID: 32503269 [TBL] [Abstract][Full Text] [Related]
2. Residues W320 and Y328 within the binding site of the μ-opioid receptor influence opiate ligand bias. Hothersall JD; Torella R; Humphreys S; Hooley M; Brown A; McMurray G; Nickolls SA Neuropharmacology; 2017 May; 118():46-58. PubMed ID: 28283391 [TBL] [Abstract][Full Text] [Related]
3. Biased μ-opioid receptor agonists diversely regulate lateral mobility and functional coupling of the receptor to its cognate G proteins. Melkes B; Hejnova L; Novotny J Naunyn Schmiedebergs Arch Pharmacol; 2016 Dec; 389(12):1289-1300. PubMed ID: 27600870 [TBL] [Abstract][Full Text] [Related]
4. The endomorphin-1/2 and dynorphin-B peptides display biased agonism at the mu opioid receptor. LaVigne J; Keresztes A; Chiem D; Streicher JM Pharmacol Rep; 2020 Apr; 72(2):465-471. PubMed ID: 32112361 [TBL] [Abstract][Full Text] [Related]
5. Assessment of structure-activity relationships and biased agonism at the Mu opioid receptor of novel synthetic opioids using a novel, stable bio-assay platform. Vasudevan L; Vandeputte M; Deventer M; Wouters E; Cannaert A; Stove CP Biochem Pharmacol; 2020 Jul; 177():113910. PubMed ID: 32179045 [TBL] [Abstract][Full Text] [Related]
6. Synthesis, biological, and structural explorations of a series of μ-opioid receptor (MOR) agonists with high G protein signaling bias. Yang Y; Wang Y; Zuo A; Li C; Wang W; Jiang W; Zhang X; Che X; Zhang Y; Wu W; Cen X; Wang H; Tian J Eur J Med Chem; 2022 Jan; 228():113986. PubMed ID: 34802839 [TBL] [Abstract][Full Text] [Related]
7. Ligand-dependent spatiotemporal signaling profiles of the μ-opioid receptor are controlled by distinct protein-interaction networks. Civciristov S; Huang C; Liu B; Marquez EA; Gondin AB; Schittenhelm RB; Ellisdon AM; Canals M; Halls ML J Biol Chem; 2019 Nov; 294(44):16198-16213. PubMed ID: 31515267 [TBL] [Abstract][Full Text] [Related]
8. Inverse agonists and neutral antagonists at mu opioid receptor (MOR): possible role of basal receptor signaling in narcotic dependence. Wang D; Raehal KM; Bilsky EJ; Sadée W J Neurochem; 2001 Jun; 77(6):1590-600. PubMed ID: 11413242 [TBL] [Abstract][Full Text] [Related]
9. Biased agonism of clinically approved μ-opioid receptor agonists and TRV130 is not controlled by binding and signaling kinetics. Pedersen MF; Wróbel TM; Märcher-Rørsted E; Pedersen DS; Møller TC; Gabriele F; Pedersen H; Matosiuk D; Foster SR; Bouvier M; Bräuner-Osborne H Neuropharmacology; 2020 Apr; 166():107718. PubMed ID: 31351108 [TBL] [Abstract][Full Text] [Related]
10. Effectiveness comparisons of G-protein biased and unbiased mu opioid receptor ligands in warm water tail-withdrawal and drug discrimination in male and female rats. Schwienteck KL; Faunce KE; Rice KC; Obeng S; Zhang Y; Blough BE; Grim TW; Negus SS; Banks ML Neuropharmacology; 2019 May; 150():200-209. PubMed ID: 30660628 [TBL] [Abstract][Full Text] [Related]
11. Molecular Dynamics Simulations to Investigate How PZM21 Affects the Conformational State of the μ-Opioid Receptor Upon Activation. Zhao Z; Huang T; Li J Int J Mol Sci; 2020 Jul; 21(13):. PubMed ID: 32630190 [TBL] [Abstract][Full Text] [Related]
12. Mu Opioids Induce Biased Signaling at the Full-Length Seven Transmembrane C-Terminal Splice Variants of the mu Opioid Receptor Gene, Oprm1. Narayan A; Hunkele A; Xu J; Bassoni DL; Pasternak GW; Pan YX Cell Mol Neurobiol; 2021 Jul; 41(5):1059-1074. PubMed ID: 33033993 [TBL] [Abstract][Full Text] [Related]